
March 28, 2024
RegMed Investors’ (RMi) pre-open: Occam’s Razor
March 27, 2024
RegMed Investors (RMi) Closing Bell: The anxiousness of the session was abrogated with a risk appetite satisfied
March 27, 2024
RegMed Investors’ (RMi) pre-open: climbing a wall of worry
March 26, 2024
RegMed Investors (RMi) Closing Bell: a negative sector close
March 26, 2024
RegMed Investors’ (RMi) pre-open: get some or none
March 25, 2024
RegMed Investors (RMi) Closing Bell: twists and turns as Monday closes barely positive and a coming end of March and Q1/24
March 25, 2024
RegMed Investors’ (RMi) pre-open: end of March and Q1/24 this week
March 22, 2024
RegMed Investors (RMi) Closing Bell: A question had been asked, are there legs to the sector?
March 22, 2024
RegMed Investors (RMi) research note – Finance: Sangamo Therapeutics (SGMO) Proposes Offering of 24,761,905 shares priced at $0.84
March 22, 2024
RegMed Investors’ (RMi) pre-open: Buy or fly, trade or fade?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors